1. Stocks
  2. Solara Active Pharma Sciences Ltd.
  3. Swot
Solara Active Pharma Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Stocks where Mutual Funds Increased Holdings in Past Month
Expensive Stars (DVM) 274.5% returns for over 5.4 years
Company with high TTM EPS Growth 413.9% returns for Nifty 500 over 5.4 years
Good quarterly growth in the recent results 254.3% returns for Nifty 500 over 4.5 years
Overbought by Money Flow Index (MFI) 477.2% returns for over 4.5 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing Revenue every Quarter for the past 4 Quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with decreasing Promoter pledge
FII / FPI or Institutions increasing their shareholding
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Near 52 Week High
Strong Momentum: Price above short, medium and long term moving averages
Big Deal (Insider and SAST) sells last month greater than 1% of total shares
Broker downgrades in price or recommendation in the past one month
MFs decreased their shareholding last quarter 190% returns for over 6.4 years
Decline in Net Profit with falling Profit Margin (QoQ)
Promoter decreasing their shareholding
Declining Net Cash Flow : Companies not able to generate net cash
High promoter stock pledges
Rising Delivery Percentage Compared to Prev Day
Companies that saw improvement in net profits, operating profit margin and revenues in the most recent quarter
Trendlynes high return technically strong value stocks (subscription) 817.3% returns for Nifty 500 over 5.2 years
High Momentum Scores (Technical Scores greater than 50) 319.5% returns for Nifty 500 over 5.1 years
Highest Recovery from 52 Week Low
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Big Deal (Insider and SAST) sells last week greater than 1% of total shares
Increase in pledged shares in the past week
Stocks with Expensive Valuations according to the Trendlyne Valuation Score 177.2% returns for Nifty 500 over 4.5 years
Increasing Trend in Non-Core Income
Insiders sold stocks
High DVM Mid and Small Caps (subscription) 848.4% returns for Nifty 500 over 7.1 years
Stringent DVM Screener - maximize returns 4153.1% returns for Nifty 500 over 5.2 years
Weekly Strategy: High Momentum Score Stocks (subscription) 71.7% returns for Nifty 500 over 1.2 years
Trendlynes growth stocks with good technical score 384.7% returns for Nifty 500 over 4.5 years
Top Losers